| Authors: |
Vincent F; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York, USA; Department of Cardiology, Regional Hospital ISSSTE Puebla, Puebla, Mexico., Redfors B; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York, USA; Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden; Department of Molecular and Clinical Medicine, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden., Kotinkaduwa LN; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York, USA., Kar S; Los Robles Regional Medical Center, Thousand Oaks, California, USA; Bakersfield Heart Hospital, Bakersfield, California, USA., Lim DS; Division of Cardiology, University of Virginia, Charlottesville, Virginia, USA., Mishell JM; Kaiser Permanente San Francisco Hospital, San Francisco, California, USA., Whisenant BK; Intermountain Medical Center, Murray, Utah, USA., Lindenfeld J; Advanced Heart Failure and Cardiac Transplantation Section, Vanderbilt Heart and Vascular Institute, Nashville, Tennessee, USA., Abraham WT; Department of Medicine, The Ohio State University, Columbus, Ohio, USA; Department of Physiology and Cell Biology, The Ohio State University, Columbus, Ohio, USA; Division of Cardiovascular Medicine, The Ohio State University, Columbus, Ohio, USA; Davis Heart and Lung Research Institute, The Ohio State University, Columbus, Ohio, USA., Mack MJ; Baylor Scott & White Heart Hospital Plano, Plano, Texas, USA., Stone GW; Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Electronic address: gregg.stone@mountsinai.org. |
